Founded in Miami in 1959, Cordis develops innovative medical technologies. Global leader in circulatory disease management devices. Pioneered intravascular stenting as effective treatment option. Conducts major breakthrough trials advancing circulatory disease management
Ureteric stents are double J-shaped catheters for urine passage. Can be placed antegrade by radiologist or retrograde by urologist. Used for obstructions, malignancies, benign strictures and retroperitoneal fibrosis
Indicated for superficial femoral artery and proximal popliteal artery. Uses unique interwoven wire technology for vessel opening. Demonstrates 4x greater compression resistance than other stents. Features 1:1 stent to vessel sizing for minimal vessel injury. Zero stent fractures reported at 1 year in over 2,000 patients
NCS occurs when SMA and aorta compress left renal vein. Syndrome affects second to middle-aged adults, with equal gender prevalence. Classic NCS is anterior, posterior NCS is less common variant
Restenosis is the recurrence of blood vessel narrowing after treatment. In-stent restenosis occurs after stent placement, post-angioplasty after balloon angioplasty. Diagnostic threshold for restenosis is ≥50% stenosis
PCI is a minimally invasive treatment for coronary artery disease. First introduced in 1977 by Andreas Gruentzig in Switzerland. Uses catheterization with stents to open narrowed arteries. Performed by interventional cardiologists in catheterization laboratories